Structure Therapeutics GPCR
NASDAQ GPCR
$32.69 -2.38 (-6.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Structure Therapeutics (GPCR) Preferred Stock Liabilities (2022)

Updated

Structure Therapeutics (GPCR) reported Preferred Stock Liabilities of $199.98 million for Q4 2022.

Analysis

Structure Therapeutics (GPCR) Preferred Stock Liabilities (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Structure Therapeutics 7.49 Bn 7.49 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 199.98 Mn
API Access

Structure Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=GPCR&period=max&api_key=YOUR_API_KEY